OPEN END-TURBO-OPTIONSSCHEIN - ABBOTT LABORATORIES Stock

Certificat

DE000TT7KRC9

Delayed Deutsche Boerse AG 02:50:31 2024-06-17 EDT
1.85 EUR +1.09% Intraday chart for OPEN END-TURBO-OPTIONSSCHEIN - ABBOTT LABORATORIES
Current month+10.24%
1 month-3.17%
Date Price Change
24-06-17 1.85 +1.09%
24-06-14 1.83 +0.55%
24-06-13 1.82 -5.21%
24-06-12 1.92 -6.80%
24-06-11 2.06 -7.62%

Delayed Quote Deutsche Boerse AG

Last update June 17, 2024 at 02:50 am

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying ABBOTT LABORATORIES
Issuer HSBC
WKN TT7KRC
ISINDE000TT7KRC9
Date issued 2021-06-04
Strike 84.11 $
Maturity Unlimited
Parity 10 : 1
Emission price 2.78
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 6.13
Lowest since issue 0.97
Spread 0.06
Spread %3.14%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
103.7 USD
Average target price
125.4 USD
Spread / Average Target
+20.92%
Consensus